| Biological variation: from principles to practice CG Fraser Amer. Assoc. for Clinical Chemistry, 2001 | 1076 | 2001 |
| Generation and application of data on biological variation in clinical chemistry GG Fraser, EK Harris Critical reviews in clinical laboratory sciences 27 (5), 409-437, 1989 | 993 | 1989 |
| The postpartum bonding questionnaire: a validation IF Brockington, C Fraser, D Wilson Archives of women's mental health 9, 233-242, 2006 | 588 | 2006 |
| Defining analytical performance specifications: consensus statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine S Sandberg, CG Fraser, AR Horvath, R Jansen, G Jones, W Oosterhuis, ... Clinical Chemistry and Laboratory Medicine (CCLM) 53 (6), 833-835, 2015 | 521 | 2015 |
| Proposals for setting generally applicable quality goals solely based on biology CG Fraser, PH Petersen, JC Libeer, C Ricos Annals of clinical biochemistry 34 (1), 8-12, 1997 | 450 | 1997 |
| Reference change values CG Fraser Clinical chemistry and laboratory medicine 50 (5), 807-812, 2012 | 262 | 2012 |
| Inherent biological variation and reference values CG Fraser Clinical Chemistry and Laboratory Medicine (CCLM) 42 (7), 758-764, 2004 | 254 | 2004 |
| Analytical performance characteristics should be judged against objective quality specifications CG Fraser, PH Petersen Clinical chemistry 45 (3), 321-323, 1999 | 249 | 1999 |
| Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry. CG Fraser, PH Petersen, C Ricos, R Haeckel European journal of clinical chemistry and clinical biochemistry: journal of …, 1992 | 242 | 1992 |
| Advances in fecal occult blood tests: the FIT revolution GP Young, EL Symonds, JE Allison, SR Cole, CG Fraser, SP Halloran, ... Digestive diseases and sciences 60, 609-622, 2015 | 223 | 2015 |
| Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer RJC Steele, PL McClements, G Libby, R Black, C Morton, J Birrell, ... Gut 58 (4), 530-535, 2009 | 219 | 2009 |
| Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT) JE Allison, CG Fraser, SP Halloran, GP Young Gut and liver 8 (2), 117, 2014 | 213 | 2014 |
| Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms C Mowat, J Digby, JA Strachan, R Wilson, FA Carey, CG Fraser, ... Gut 65 (9), 1463-1469, 2016 | 199 | 2016 |
| The application of theoretical goals based on biological variation data in proficiency testing. CG Fraser Archives of Pathology & Laboratory Medicine 112 (4), 404-415, 1988 | 195 | 1988 |
| Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study RS MacWalter, SYS Wong, KYK Wong, G Stewart, CG Fraser, HW Fraser, ... Stroke 33 (6), 1630-1635, 2002 | 180 | 2002 |
| Biological variation in clinical chemistry. An update: collated data, 1988-1991. CG Fraser Archives of pathology & laboratory medicine 116 (9), 916-923, 1992 | 176 | 1992 |
| Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site RJC Steele, P McClements, C Watling, G Libby, D Weller, DH Brewster, ... Gut 61 (4), 576-581, 2012 | 175 | 2012 |
| Consensus agreement D Kenny, CG Fraser, PH Petersen, A Kallner Scandinavian Journal of Clinical and Laboratory Investigation 59 (7), 585-585, 1999 | 173 | 1999 |
| Severe disorders of the mother–infant relationship: definitions and frequency IF Brockington, HM Aucamp, C Fraser Archives of women's mental health 9, 243-251, 2006 | 172 | 2006 |
| Objective criteria for partitioning Gaussian-distributed reference values into subgroups A Lahti, P Hyltoft Petersen, JC Boyd, CG Fraser, N Jørgensen Clinical chemistry 48 (2), 338-352, 2002 | 172 | 2002 |
